世界の全身性アスペルギルス症及び全身性カンジダ症治療市場予測2023-2029：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他

【英語タイトル】Systemic Aspergillosis and Systemic Candidiasis Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23FB2226）

・商品コード：MMG23FB2226
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年2月
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模と予測を収録しています。・世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：売上、2018年-2023年、2024年-2029年
・世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ボリコナゾール」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

全身性アスペルギルス症及び全身性カンジダ症治療のグローバル主要企業は、Basilea Pharmaceutica、Astellas Pharma、Ferrer International、Pacgen Life Science、NovaDigm Therapeutics、Cidara Therapeutics、Amplyx Pharmaceuticals、Pfizer、Novartis、Sanofi、Merck、Bayer、GlaxoSmithKline、Abbott、Ciplaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、全身性アスペルギルス症及び全身性カンジダ症治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：タイプ別市場シェア、2022年
・ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：用途別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：用途別市場シェア、2022年
・慢性肺アスペルギルス症（CPA）、アレルギー性気管支肺アスペルギルス症（ABPA）、消化管カンジダ症、泌尿生殖器カンジダ症、その他

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル売上、2018年-2023年
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル売上シェア、2022年
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル販売量、2018年-2023年
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Basilea Pharmaceutica、Astellas Pharma、Ferrer International、Pacgen Life Science、NovaDigm Therapeutics、Cidara Therapeutics、Amplyx Pharmaceuticals、Pfizer、Novartis、Sanofi、Merck、Bayer、GlaxoSmithKline、Abbott、Cipla

*************************************************************

・調査・分析レポートの概要
全身性アスペルギルス症及び全身性カンジダ症治療市場の定義
市場セグメント
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模：2022年 VS 2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの全身性アスペルギルス症及び全身性カンジダ症治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の全身性アスペルギルス症及び全身性カンジダ症治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他
全身性アスペルギルス症及び全身性カンジダ症治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：慢性肺アスペルギルス症（CPA）、アレルギー性気管支肺アスペルギルス症（ABPA）、消化管カンジダ症、泌尿生殖器カンジダ症、その他
全身性アスペルギルス症及び全身性カンジダ症治療の用途別グローバル売上・予測

・地域別市場分析
地域別全身性アスペルギルス症及び全身性カンジダ症治療市場規模 2022年と2029年
地域別全身性アスペルギルス症及び全身性カンジダ症治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Basilea Pharmaceutica、Astellas Pharma、Ferrer International、Pacgen Life Science、NovaDigm Therapeutics、Cidara Therapeutics、Amplyx Pharmaceuticals、Pfizer、Novartis、Sanofi、Merck、Bayer、GlaxoSmithKline、Abbott、Cipla
…

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Overall Market Size
2.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size: 2022 VS 2029
2.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players in Global Market
3.2 Top Global Systemic Aspergillosis and Systemic Candidiasis Treatment Companies Ranked by Revenue
3.3 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Systemic Aspergillosis and Systemic Candidiasis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Systemic Aspergillosis and Systemic Candidiasis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Markets, 2022 & 2029
4.1.2 Voriconazole
4.1.3 Liposomal Amphotericin B
4.1.4 Systemic Oral Azoles
4.1.5 Topical Antifungal Agents
4.1.6 Others
4.2 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue & Forecasts
4.2.1 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2023
4.2.2 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2024-2029
4.2.3 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2022 & 2029
5.1.2 Chronic Pulmonary Aspergillosis (CPA)
5.1.3 Allergic Bronchopulmonary Aspergillosis (ABPA)
5.1.4 Gastrointestinal Candidiasis
5.1.5 Genitourinary Tract Candidiasis
5.1.6 Others
5.2 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue & Forecasts
5.2.1 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2023
5.2.2 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2024-2029
5.2.3 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2022 & 2029
6.2 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue & Forecasts
6.2.1 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2023
6.2.2 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2024-2029
6.2.3 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.3.2 US Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.3.3 Canada Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.3.4 Mexico Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.4.2 Germany Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.3 France Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.4 U.K. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.5 Italy Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.6 Russia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.8 Benelux Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.5.2 China Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.3 Japan Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.4 South Korea Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.6 India Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.6.2 Brazil Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.6.3 Argentina Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.7.2 Turkey Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7.3 Israel Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7.5 UAE Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
7 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies Profiles
7.1 Basilea Pharmaceutica
7.1.1 Basilea Pharmaceutica Company Summary
7.1.2 Basilea Pharmaceutica Business Overview
7.1.3 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.1.4 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.1.5 Basilea Pharmaceutica Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.2.4 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 Ferrer International
7.3.1 Ferrer International Company Summary
7.3.2 Ferrer International Business Overview
7.3.3 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.3.4 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.3.5 Ferrer International Key News & Latest Developments
7.4 Pacgen Life Science
7.4.1 Pacgen Life Science Company Summary
7.4.2 Pacgen Life Science Business Overview
7.4.3 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.4.4 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.4.5 Pacgen Life Science Key News & Latest Developments
7.5 NovaDigm Therapeutics
7.5.1 NovaDigm Therapeutics Company Summary
7.5.2 NovaDigm Therapeutics Business Overview
7.5.3 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.5.4 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.5.5 NovaDigm Therapeutics Key News & Latest Developments
7.6 Cidara Therapeutics
7.6.1 Cidara Therapeutics Company Summary
7.6.2 Cidara Therapeutics Business Overview
7.6.3 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.6.4 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.6.5 Cidara Therapeutics Key News & Latest Developments
7.7 Amplyx Pharmaceuticals
7.7.1 Amplyx Pharmaceuticals Company Summary
7.7.2 Amplyx Pharmaceuticals Business Overview
7.7.3 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.7.4 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.7.5 Amplyx Pharmaceuticals Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.8.4 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.9.4 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.10.4 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.11.4 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Bayer
7.12.1 Bayer Company Summary
7.12.2 Bayer Business Overview
7.12.3 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.12.4 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.12.5 Bayer Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.13.4 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.13.5 GlaxoSmithKline Key News & Latest Developments
7.14 Abbott
7.14.1 Abbott Company Summary
7.14.2 Abbott Business Overview
7.14.3 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.14.4 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.14.5 Abbott Key News & Latest Developments
7.15 Cipla
7.15.1 Cipla Company Summary
7.15.2 Cipla Business Overview
7.15.3 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.15.4 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.15.5 Cipla Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Opportunities & Trends in Global Market
Table 2. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Drivers in Global Market
Table 3. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Restraints in Global Market
Table 4. Key Players of Systemic Aspergillosis and Systemic Candidiasis Treatment in Global Market
Table 5. Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Systemic Aspergillosis and Systemic Candidiasis Treatment Product Type
Table 9. List of Global Tier 1 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Basilea Pharmaceutica Company Summary
Table 31. Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 32. Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Basilea Pharmaceutica Key News & Latest Developments
Table 34. Astellas Pharma Company Summary
Table 35. Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 36. Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Pharma Key News & Latest Developments
Table 38. Ferrer International Company Summary
Table 39. Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 40. Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Ferrer International Key News & Latest Developments
Table 42. Pacgen Life Science Company Summary
Table 43. Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 44. Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Pacgen Life Science Key News & Latest Developments
Table 46. NovaDigm Therapeutics Company Summary
Table 47. NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 48. NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. NovaDigm Therapeutics Key News & Latest Developments
Table 50. Cidara Therapeutics Company Summary
Table 51. Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 52. Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Cidara Therapeutics Key News & Latest Developments
Table 54. Amplyx Pharmaceuticals Company Summary
Table 55. Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 56. Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Amplyx Pharmaceuticals Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 60. Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 64. Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 68. Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 72. Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Bayer Company Summary
Table 75. Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 76. Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Bayer Key News & Latest Developments
Table 78. GlaxoSmithKline Company Summary
Table 79. GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 80. GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. GlaxoSmithKline Key News & Latest Developments
Table 82. Abbott Company Summary
Table 83. Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 84. Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Abbott Key News & Latest Developments
Table 86. Cipla Company Summary
Table 87. Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offerings
Table 88. Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue (US$, Mn) & (2018-2023)
Table 89. Cipla Key News & Latest Developments
List of Figures
Figure 1. Systemic Aspergillosis and Systemic Candidiasis Treatment Segment by Type in 2022
Figure 2. Systemic Aspergillosis and Systemic Candidiasis Treatment Segment by Application in 2022
Figure 3. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in 2022
Figure 8. By Type - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 16. US Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 28. China Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

★調査レポート[世界の全身性アスペルギルス症及び全身性カンジダ症治療市場予測2023-2029：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他] (コード：MMG23FB2226)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の全身性アスペルギルス症及び全身性カンジダ症治療市場予測2023-2029：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他]についてメールでお問い合わせ

MarketReport.jp

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場予測2023-2029：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp